Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins

K. Akashi, K. Nagasawa, T. Mayumi, E. Yokota, N. Oochi, T. Kusaba

研究成果: ジャーナルへの寄稿記事

50 引用 (Scopus)

抜粋

Two cases of refractory systemic lupus erythematosus (SLE) were successfully treated with intravenous immunoglobulins (IVIg). In Case 1, the immediate recovery from severe pancytopenia and the improvement of proteinuria were observed, following IVIg therapy in high doses (450 mg/kg) for 5 consecutive days. In Case 2, 3 courses of IVIg therapy (100 mg/kg) for 6 to 8 days resulted in a significant reduction of massive proteinuria. In both cases, the improvement of immunological variables was also seen.

元の言語英語
ページ(範囲)375-379
ページ数5
ジャーナルJournal of Rheumatology
17
発行部数3
出版物ステータス出版済み - 1 1 1990

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

これを引用

Akashi, K., Nagasawa, K., Mayumi, T., Yokota, E., Oochi, N., & Kusaba, T. (1990). Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. Journal of Rheumatology, 17(3), 375-379.